Asymptomatic carotid artery stenosis is associated with increased Alzheimer's disease and non-Alzheimer's disease dementia risk

被引:0
作者
Vitali, Francesca [1 ,2 ]
Torrandell-Haro, Georgina [2 ]
Branigan, Gregory [3 ]
Aristizabal, Juan Arias [4 ]
Reiman, Eric [5 ]
Bedrick, Edward J. [6 ]
Brinton, Roberta Diaz [2 ]
Weinkauf, Craig [4 ]
机构
[1] Univ Arizona, Coll Med, Neurol, Tucson, AZ USA
[2] Univ Arizona, Coll Med, Ctr Innovat Brain Sci, Tucson, AZ USA
[3] Univ Arizona, Coll Med, Tucson, AZ USA
[4] Univ Arizona, Coll Med, Dept Surg, Tucson, AZ 85724 USA
[5] Banner Alzheimers Inst, Phoenix, AZ USA
[6] Univ Arizona, Med Ctr, Ctr Biomed Informat & Biostat, Univ Campus, Tucson, AZ USA
关键词
Carotid Stenosis; Neurodegenerative Diseases; Risk Factors; Brain; History; COGNITIVE IMPAIRMENT; VASCULAR CONTRIBUTIONS; ATHEROSCLEROSIS; POPULATION; PREVALENCE; DYSFUNCTION; MANAGEMENT; STROKE;
D O I
10.1136/svn-2024-003164
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background In the absence of a cerebrovascular accident, whether asymptomatic extracranial carotid atherosclerotic disease (aECAD) affects Alzheimer's disease (AD) and non-AD dementia risk is not clear. Understanding whether aECAD is associated with an increased risk for AD is important as it is present in roughly 10% of the population over 60 and could represent a modifiable risk factor for AD and non-AD dementia. Methods This retrospective cohort study analysed Mariner insurance claims. Enrolment criteria included patients aged 55 years or older with at least 5 years of data and no initial dementia diagnosis. Subjects with and without aECAD were evaluated for subsequent AD and non-AD dementia diagnoses. Propensity score matching was performed using confounding factors identified by logistic regression. chi(2) tests and Kaplan-Meier survival curves were used to evaluate the impact of aECAD diagnosis on AD and non-AD dementia risk over time. Results 767 354 patients met enrolment criteria. After propensity score matching, 62 963 subjects with aECAD and 62 963 subjects without ECAD were followed through data records. The aECAD cohort exhibited an increased relative risk of 1.22 (95% CI 1.15 to 1.29, p<0.001) for AD and 1.48 (95% CI 1.38 to 1.59, p<0.001) for non-AD dementias compared with the propensity score-matched cohort without aECAD. The increased AD risk associated with aECAD was evident in patients younger than 75 years old and was less apparent in patients over 75 years of age. Conclusions aECAD is associated with an increased risk of developing AD and non-AD dementias. These findings underscore the need for further prospective evaluation of interactions between aECAD and dementia, with potential implications for change of clinical care in both of these large patient populations.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] VEGF genetic variability is associated with increased risk of developing Alzheimer's disease
    Del Bo, Roberto
    Ghezzi, Serena
    Scarpini, Elio
    Bresolin, Nereo
    Comi, Giacomo Pietro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 283 (1-2) : 66 - 68
  • [32] Reduce the Risk of Dementia; Early Diagnosis of Alzheimer's Disease
    Jakhmola, Shweta
    Jha, Hem Chandra
    MACHINE INTELLIGENCE AND SIGNAL ANALYSIS, 2019, 748 : 621 - 632
  • [33] Carotid and Vertebral Arterial Variations in Alzheimer's Disease
    Zhou, Rui
    Liu, Dong
    Yu, Ke
    Chen, Yang
    Li, Ling
    Xu, Jianzhong
    Zhou, Huadong
    CURRENT ALZHEIMER RESEARCH, 2015, 12 (04) : 368 - 376
  • [34] Vitamin E in aging, dementia, and Alzheimer's disease
    Joshi, Yash B.
    Pratico, Domenico
    BIOFACTORS, 2012, 38 (02) : 90 - 97
  • [35] Neuropsychiatric Symptoms in Alzheimer's Disease and Vascular Dementia
    Echavarri, Carmen
    Burgmans, Saartje
    Uylings, Harry
    Cuesta, Manuel J.
    Peralta, Victor
    Kamphorst, Wouter
    Rozemuller, Annemieke J. M.
    Verhey, Frans R. J.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 (03) : 715 - 721
  • [36] Mixed Dementia in Clinical Trials of Alzheimer's Disease
    Massoud, Fadi
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2012, 39 (05) : 566 - 567
  • [37] Caffeine as a Protective Factor in Dementia and Alzheimer's Disease
    Eskelinen, Marjo H.
    Kivipelto, Miia
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 : S167 - S174
  • [38] Polygenic risk of Alzheimer's disease in the Faroe Islands
    Johansen, Malan
    Joensen, Sofus
    Restorff, Marjun
    Stora, Tormodur
    Christy, Darren
    Gustavsson, Emil K.
    Bian, Jiang
    Guo, Yi
    Farrer, Matthew J.
    Petersen, Maria Skaalum
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (08) : 2192 - 2200
  • [39] Patient characteristics associated with screening positive for Alzheimer's disease and related dementia
    Fowler, Nicole R.
    Perkins, Anthony J.
    Gao, Sujuan
    Sachs, Greg A.
    Uebelhor, Austin K.
    Boustani, Malaz A.
    CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 1779 - 1785
  • [40] RISK FACTORS FOR ALZHEIMER'S DISEASE AND RELATED DEMENTIA DIAGNOSES IN AMERICAN INDIANS
    Carty, Cara L.
    Noonan, Carolyn
    Muller, Clemma
    Saner, Don
    Reiman, Eric M.
    Buchwald, Dedra
    Bell, Ronny A.
    Nelson, Lonnie A.
    ETHNICITY & DISEASE, 2020, 30 (04) : 671 - 680